Related references
Note: Only part of the references are listed.Brain cell type-specific cholesterol metabolism and implications for learning and memory
Dingfeng Li et al.
TRENDS IN NEUROSCIENCES (2022)
Apolipoprotein E and Alzheimer's Disease: Findings, Hypotheses, and Potential Mechanisms
Nicole Koutsodendris et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)
PCSK9 acts as a key regulator of Aβ clearance across the blood-brain barrier
Alexander D. Mazura et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
New insights into the genetic etiology of Alzheimer's disease and related dementias
Celine Bellenguez et al.
NATURE GENETICS (2022)
Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release
Rafael Jaen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Therapeutics of Alzheimer's Disease: Recent Developments
Scott Burns et al.
ANTIOXIDANTS (2022)
Staging of Alzheimer?s disease: past, present and future perspectives
Joseph Therriault et al.
TRENDS IN MOLECULAR MEDICINE (2022)
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer's Disease
Bianca Papotti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
PCSK9 and LRP5 in macrophage lipid internalization and inflammation
Lina Badimon et al.
CARDIOVASCULAR RESEARCH (2021)
Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model
Jackie K. Y. Lau et al.
SCIENTIFIC REPORTS (2021)
Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease
Stefania Forner et al.
SCIENTIFIC DATA (2021)
The role of pathological tau in synaptic dysfunction in Alzheimer's diseases
Moxin Wu et al.
TRANSLATIONAL NEURODEGENERATION (2021)
HMGB1/RAGE/TLR4 axis and glutamate as novel targets for PCSK9 inhibitor in high fat cholesterol diet induced cognitive impairment and amyloidosis
Sally A. Abuelezz et al.
LIFE SCIENCES (2021)
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer's Disease
Massimiliano Runfola et al.
PHARMACEUTICALS (2021)
A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice
Eleonora Daini et al.
NEUROSCIENCE LETTERS (2021)
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study
Adrian L. Oblak et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects
Femke M. Feringa et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease
Maya Koronyo-Hamaoui et al.
BRAIN (2020)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats
Busarin Arunsak et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
The Role of Astrocytes in CNS Inflammation
Federico Giovannoni et al.
TRENDS IN IMMUNOLOGY (2020)
A quantitative LC-MS/MS method for analysis of mitochondrial-specific oxysterol metabolism
Khushboo Borah et al.
REDOX BIOLOGY (2020)
A Unifying Hypothesis for Alzheimer's Disease: From Plaques to Neurodegeneration
Frances A. Edwards
TRENDS IN NEUROSCIENCES (2019)
Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer's Disease
Maria Pia Adorni et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study
Cynthia Picard et al.
PLOS ONE (2019)
Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac lschemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation
Nattayaporn Apaijai et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
PCSK9 Concentrations in Cerebrospinal Fluid Are Not Specifically Increased in Alzheimer's Disease
Helene Courtemanche et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Loss-of-Function PCSK9 Mutations Are Not Associated With Alzheimer Disease
Martine Paquette et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2018)
PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque
A. Liu et al.
JOURNAL OF INTERNAL MEDICINE (2018)
PCSK9 induces a pro-inflammatory response in macrophages
Chiara Ricci et al.
SCIENTIFIC REPORTS (2018)
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response
Giovanna Rigillo et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease
Francesca Zimetti et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway
Lu-Shan Liu et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
Zhi-Han Tang et al.
ATHEROSCLEROSIS (2017)
Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease
Katherine R. Sadleir et al.
ACTA NEUROPATHOLOGICA (2016)
Central Nervous System Lipoproteins ApoE and Regulation of Cholesterol Metabolism
Robert W. Mahley
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer's disease
Yosef Koronyo et al.
BRAIN (2015)
Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10
Beatriz Almolda et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Astrocyte-Targeted Production of IL-10 Induces Changes in Microglial Reactivity and Reduces Motor Neuron Death After Facial Nerve Axotomy
Nadia Villacampa et al.
GLIA (2015)
Regulation of inflammasome activation
Si Ming Man et al.
IMMUNOLOGICAL REVIEWS (2015)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer's Disease
Kurt M. Lucin et al.
NEURON (2013)
PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling
Kai Kysenius et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain
Mali Liu et al.
JOURNAL OF LIPID RESEARCH (2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2
Steve Poirier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
Masuo Ohno et al.
NEUROBIOLOGY OF DISEASE (2007)
Proapoptotic effects of NARC 1 (=PCSK9), the gene encoding a novel serine proteinase
Brendan Bingham et al.
CYTOMETRY PART A (2006)
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Charles V. Vorhees et al.
NATURE PROTOCOLS (2006)
The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1):: Liver regeneration and neuronal differentiation
NG Seidah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cholesterol metabolism in the brain
JM Dietschy et al.
CURRENT OPINION IN LIPIDOLOGY (2001)